JAMES CHENG-CHUNG WEI2026-10-162026-10-162023-07-01Pure ID: 15372989Pure UUID: c73da373-1cf8-4afb-98bb-3efea6f3156210.1136/annrheumdis-2021-220788https://www.scopus.com/pages/publications/85163265124https://scholars.csmu.edu.tw/handle/123456789/24025enResponse to'Correspondence on 'Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 trial'' by Zhao and Huangjournal article